Drug Discovery Informatics

Drug Discovery Informatics Comprehensive Study by Type (Software, Services), Function (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Libraries and Database Preparation, Other Functions), End-user (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Other End Users) Players and Region - Global Market Outlook to 2030

Drug Discovery Informatics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Drug Discovery Informatics
Drug discovery informatics involves the creation of systems that can work more efficiently with large sets of clinical trial and treatment data created by the scientists when conducting research into treatments for specific diseases or for certain patient demographics.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.3%


The demand for Doctor house calls is increasing. The industry is segmented, but it is predicted to grow as the rising of smart cities and the increased prevalence of OOH advertising, among other factors, drive the market forward. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from the competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaged in strategic global expansion to maintain their Market Position. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Drug Discovery Informatics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

IBM (United States), Infosys Ltd. (India), Schrödinger (United States), PerkinElmer (United States), Thermo Fisher Scientific (United States), GVK Biosciences (India) and Novo Informatics Pvt. Ltd. (India) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Drug Discovery Informatics market by Type (Software and Services) and Region.



On the basis of geography, the market of Drug Discovery Informatics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Function, the sub-segment i.e. Sequencing and Target Data Analysis will boost the Drug Discovery Informatics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Pharmaceutical and Biotechnology Companies will boost the Drug Discovery Informatics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
High Demand from Pharmaceutical Companies and Increased Research and Development Activities

Challenges:
Lack of Skilled Workforce

Restraints:
High Cost Associated With Drug Discovery Informatics Software

Opportunities:
Growing Healthcare Industry Worldwide and Expirations of the Patents about Drugs

Market Leaders and their expansionary development strategies
In December 2023, Clarivate Plc announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more.
In May 2023, Google Cloud announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. Available worldwide today, the Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Mult omics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.


Key Target Audience
Drug Discovery Informatics Providers, Research Professionals, Emerging Companies, Government Body & Associations and End-user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Software
  • Services
By Function
  • Sequencing and Target Data Analysis
  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Other Functions

By End-user
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROS)
  • Other End Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand from Pharmaceutical Companies
      • 3.2.2. Increased Research and Development Activities
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Workforce
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Discovery Informatics, by Type, Function, End-user and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Drug Discovery Informatics (Value)
      • 5.2.1. Global Drug Discovery Informatics by: Type (Value)
        • 5.2.1.1. Software
        • 5.2.1.2. Services
      • 5.2.2. Global Drug Discovery Informatics by: Function (Value)
        • 5.2.2.1. Sequencing and Target Data Analysis
        • 5.2.2.2. Docking
        • 5.2.2.3. Molecular Modeling
        • 5.2.2.4. Libraries and Database Preparation
        • 5.2.2.5. Other Functions
      • 5.2.3. Global Drug Discovery Informatics by: End-user (Value)
        • 5.2.3.1. Pharmaceutical and Biotechnology Companies
        • 5.2.3.2. Contract Research Organizations (CROS)
        • 5.2.3.3. Other End Users
      • 5.2.4. Global Drug Discovery Informatics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Drug Discovery Informatics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IBM (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Infosys Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Schrödinger (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GVK Biosciences (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novo Informatics Pvt. Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Drug Discovery Informatics Sale, by Type, Function, End-user and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Drug Discovery Informatics (Value)
      • 7.2.1. Global Drug Discovery Informatics by: Type (Value)
        • 7.2.1.1. Software
        • 7.2.1.2. Services
      • 7.2.2. Global Drug Discovery Informatics by: Function (Value)
        • 7.2.2.1. Sequencing and Target Data Analysis
        • 7.2.2.2. Docking
        • 7.2.2.3. Molecular Modeling
        • 7.2.2.4. Libraries and Database Preparation
        • 7.2.2.5. Other Functions
      • 7.2.3. Global Drug Discovery Informatics by: End-user (Value)
        • 7.2.3.1. Pharmaceutical and Biotechnology Companies
        • 7.2.3.2. Contract Research Organizations (CROS)
        • 7.2.3.3. Other End Users
      • 7.2.4. Global Drug Discovery Informatics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Discovery Informatics: by Type(USD Million)
  • Table 2. Drug Discovery Informatics Software , by Region USD Million (2018-2023)
  • Table 3. Drug Discovery Informatics Services , by Region USD Million (2018-2023)
  • Table 4. Drug Discovery Informatics: by Function(USD Million)
  • Table 5. Drug Discovery Informatics Sequencing and Target Data Analysis , by Region USD Million (2018-2023)
  • Table 6. Drug Discovery Informatics Docking , by Region USD Million (2018-2023)
  • Table 7. Drug Discovery Informatics Molecular Modeling , by Region USD Million (2018-2023)
  • Table 8. Drug Discovery Informatics Libraries and Database Preparation , by Region USD Million (2018-2023)
  • Table 9. Drug Discovery Informatics Other Functions , by Region USD Million (2018-2023)
  • Table 10. Drug Discovery Informatics: by End-user(USD Million)
  • Table 11. Drug Discovery Informatics Pharmaceutical and Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 12. Drug Discovery Informatics Contract Research Organizations (CROS) , by Region USD Million (2018-2023)
  • Table 13. Drug Discovery Informatics Other End Users , by Region USD Million (2018-2023)
  • Table 14. South America Drug Discovery Informatics, by Country USD Million (2018-2023)
  • Table 15. South America Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 16. South America Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 17. South America Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 18. Brazil Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 19. Brazil Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 20. Brazil Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 21. Argentina Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 22. Argentina Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 23. Argentina Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 24. Rest of South America Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 26. Rest of South America Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 27. Asia Pacific Drug Discovery Informatics, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 30. Asia Pacific Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 31. China Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 32. China Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 33. China Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 34. Japan Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 35. Japan Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 36. Japan Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 37. India Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 38. India Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 39. India Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 40. South Korea Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 41. South Korea Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 42. South Korea Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 43. Taiwan Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 44. Taiwan Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 45. Taiwan Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 46. Australia Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 47. Australia Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 48. Australia Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 52. Europe Drug Discovery Informatics, by Country USD Million (2018-2023)
  • Table 53. Europe Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 54. Europe Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 55. Europe Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 56. Germany Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 57. Germany Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 58. Germany Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 59. France Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 60. France Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 61. France Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 62. Italy Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 63. Italy Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 64. Italy Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 65. United Kingdom Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 67. United Kingdom Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 68. Netherlands Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 69. Netherlands Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 70. Netherlands Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 71. Rest of Europe Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 73. Rest of Europe Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 74. MEA Drug Discovery Informatics, by Country USD Million (2018-2023)
  • Table 75. MEA Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 76. MEA Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 77. MEA Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 78. Middle East Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 79. Middle East Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 80. Middle East Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 81. Africa Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 82. Africa Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 83. Africa Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 84. North America Drug Discovery Informatics, by Country USD Million (2018-2023)
  • Table 85. North America Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 86. North America Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 87. North America Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 88. United States Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 89. United States Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 90. United States Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 91. Canada Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 92. Canada Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 93. Canada Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 94. Mexico Drug Discovery Informatics, by Type USD Million (2018-2023)
  • Table 95. Mexico Drug Discovery Informatics, by Function USD Million (2018-2023)
  • Table 96. Mexico Drug Discovery Informatics, by End-user USD Million (2018-2023)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Drug Discovery Informatics: by Type(USD Million)
  • Table 105. Drug Discovery Informatics Software , by Region USD Million (2025-2030)
  • Table 106. Drug Discovery Informatics Services , by Region USD Million (2025-2030)
  • Table 107. Drug Discovery Informatics: by Function(USD Million)
  • Table 108. Drug Discovery Informatics Sequencing and Target Data Analysis , by Region USD Million (2025-2030)
  • Table 109. Drug Discovery Informatics Docking , by Region USD Million (2025-2030)
  • Table 110. Drug Discovery Informatics Molecular Modeling , by Region USD Million (2025-2030)
  • Table 111. Drug Discovery Informatics Libraries and Database Preparation , by Region USD Million (2025-2030)
  • Table 112. Drug Discovery Informatics Other Functions , by Region USD Million (2025-2030)
  • Table 113. Drug Discovery Informatics: by End-user(USD Million)
  • Table 114. Drug Discovery Informatics Pharmaceutical and Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 115. Drug Discovery Informatics Contract Research Organizations (CROS) , by Region USD Million (2025-2030)
  • Table 116. Drug Discovery Informatics Other End Users , by Region USD Million (2025-2030)
  • Table 117. South America Drug Discovery Informatics, by Country USD Million (2025-2030)
  • Table 118. South America Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 119. South America Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 120. South America Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 121. Brazil Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 122. Brazil Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 123. Brazil Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 124. Argentina Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 125. Argentina Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 126. Argentina Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 127. Rest of South America Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 128. Rest of South America Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 129. Rest of South America Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 130. Asia Pacific Drug Discovery Informatics, by Country USD Million (2025-2030)
  • Table 131. Asia Pacific Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 132. Asia Pacific Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 133. Asia Pacific Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 134. China Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 135. China Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 136. China Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 137. Japan Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 138. Japan Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 139. Japan Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 140. India Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 141. India Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 142. India Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 143. South Korea Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 144. South Korea Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 145. South Korea Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 146. Taiwan Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 147. Taiwan Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 148. Taiwan Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 149. Australia Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 150. Australia Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 151. Australia Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 155. Europe Drug Discovery Informatics, by Country USD Million (2025-2030)
  • Table 156. Europe Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 157. Europe Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 158. Europe Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 159. Germany Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 160. Germany Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 161. Germany Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 162. France Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 163. France Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 164. France Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 165. Italy Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 166. Italy Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 167. Italy Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 168. United Kingdom Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 169. United Kingdom Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 170. United Kingdom Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 171. Netherlands Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 172. Netherlands Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 173. Netherlands Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 174. Rest of Europe Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 175. Rest of Europe Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 176. Rest of Europe Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 177. MEA Drug Discovery Informatics, by Country USD Million (2025-2030)
  • Table 178. MEA Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 179. MEA Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 180. MEA Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 181. Middle East Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 182. Middle East Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 183. Middle East Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 184. Africa Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 185. Africa Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 186. Africa Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 187. North America Drug Discovery Informatics, by Country USD Million (2025-2030)
  • Table 188. North America Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 189. North America Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 190. North America Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 191. United States Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 192. United States Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 193. United States Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 194. Canada Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 195. Canada Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 196. Canada Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 197. Mexico Drug Discovery Informatics, by Type USD Million (2025-2030)
  • Table 198. Mexico Drug Discovery Informatics, by Function USD Million (2025-2030)
  • Table 199. Mexico Drug Discovery Informatics, by End-user USD Million (2025-2030)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Discovery Informatics: by Type USD Million (2018-2023)
  • Figure 5. Global Drug Discovery Informatics: by Function USD Million (2018-2023)
  • Figure 6. Global Drug Discovery Informatics: by End-user USD Million (2018-2023)
  • Figure 7. South America Drug Discovery Informatics Share (%), by Country
  • Figure 8. Asia Pacific Drug Discovery Informatics Share (%), by Country
  • Figure 9. Europe Drug Discovery Informatics Share (%), by Country
  • Figure 10. MEA Drug Discovery Informatics Share (%), by Country
  • Figure 11. North America Drug Discovery Informatics Share (%), by Country
  • Figure 12. Global Drug Discovery Informatics share by Players 2023 (%)
  • Figure 13. Global Drug Discovery Informatics share by Players (Top 3) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 16. IBM (United States) Revenue: by Geography 2023
  • Figure 17. Infosys Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 18. Infosys Ltd. (India) Revenue: by Geography 2023
  • Figure 19. Schrödinger (United States) Revenue, Net Income and Gross profit
  • Figure 20. Schrödinger (United States) Revenue: by Geography 2023
  • Figure 21. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 22. PerkinElmer (United States) Revenue: by Geography 2023
  • Figure 23. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 24. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 25. GVK Biosciences (India) Revenue, Net Income and Gross profit
  • Figure 26. GVK Biosciences (India) Revenue: by Geography 2023
  • Figure 27. Novo Informatics Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 28. Novo Informatics Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 29. Global Drug Discovery Informatics: by Type USD Million (2025-2030)
  • Figure 30. Global Drug Discovery Informatics: by Function USD Million (2025-2030)
  • Figure 31. Global Drug Discovery Informatics: by End-user USD Million (2025-2030)
  • Figure 32. South America Drug Discovery Informatics Share (%), by Country
  • Figure 33. Asia Pacific Drug Discovery Informatics Share (%), by Country
  • Figure 34. Europe Drug Discovery Informatics Share (%), by Country
  • Figure 35. MEA Drug Discovery Informatics Share (%), by Country
  • Figure 36. North America Drug Discovery Informatics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • IBM (United States)
  • Infosys Ltd. (India)
  • Schrödinger (United States)
  • PerkinElmer (United States)
  • Thermo Fisher Scientific (United States)
  • GVK Biosciences (India)
  • Novo Informatics Pvt. Ltd. (India)
Select User Access Type

Key Highlights of Report


Apr 2024 250 Pages 97 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Drug Discovery Informatics Quantitative research analysis
Drug Discovery Informatics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as IBM (United States), Infosys Ltd. (India), Schrödinger (United States), PerkinElmer (United States), Thermo Fisher Scientific (United States), GVK Biosciences (India) and Novo Informatics Pvt. Ltd. (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Drug Discovery Informatics Market during projected period 2023-2030.
The Drug Discovery Informatics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Drug Discovery Informatics Report?

Have a Query? Click Here

Other Related Reports

Drug Transport Technology Comprehensive Study by Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmu...
$ 3750
IVF Services Comprehensive Study by Procedure (Intracytoplasmic Sperm Injection (ICSI-IVF), Non- ICSI-IVF, Intrauterine Insemination), Offering (IVF drugs, IVF media, Reagents, Other), Cycle Type (Fr...
$ 3750
Dental Insurance Services Comprehensive Study by Type (Dental Preferred Provider Organizations (DPPO), Dental Health Maintenance Organizations (DHMO), Dental Indemnity Plans, Others), Application (In...
$ 3650
Neurosyphilis Comprehensive Study by Type (Asymptomatic Neurosyphilis, Meningeal Neurosyphilis, Meningovascular Neurosyphilis, General Paresis, Tabes Dorsalis), Application (Hospital, Clinics, Others...
$ 3800
Cosmetic Dentistry Comprehensive Study by Type (Teeth Whitening, Dental Veneers, Dental Bonding, Dental Implants, Dental Crowns, Inlays & Onlays, Others), Application (Hospitals, Cosmetic Centers, De...
$ 3350
Emergency Telemedicine Services Comprehensive Study by Type (Tele-consultation, Tele-monitoring, Tele-education, Tele-care, Tele-training, Tele-surgery), Disease (Cardiology, Dermatology, Neurology, ...
$ 3800